My name is Inna Gertsenshteyn (EE-nah  GURTZ-en-shtINE). 

I received my Ph.D. in Medical Physics from the University of Chicago in 2022, followed by a postdoctoral fellowship at the Gordon Center for Medical Imaging at Massachusetts General Hospital and Harvard Medical School. I received my B.A. in Physics from Boston University in 2015.

My general research interests are in anything to do with multimodal imaging and image analysis. Outside of academia, I enjoy hosting house concerts, coffee dates with friends, going on walks, watching films, and reading. 

News and upcoming presentations 

February 2024: Attended the SNMMI Midwinter Meeting in Orlando, FL.

October 2023: Joined Invicro as an Associate Study Director in Discovery Research.

June 2023: Poster presentations at SNMMI for our work on 1) nanoparticle brachytherapy with [177Lu]Lu-Ferumoxytol, and 2) imaging the mitochondrial membrane potential.

March 29th, 2023: Poster presentation at the Scientific Advisory Committee Virtual Meeting: "Nanoparticle Brachytherapy with Peritumoral [177Lu]Lu-Ferumoxytol Inhibits Glioma Xenograft Growth."

March 2023: Appointed as 2023-2025 intern for the Center for Molecular Imaging Innovation and Translation Board of Directors at SNMMI.

September 1st, 2022: Moved back to Boston for my postdoctoral fellowship at the Gordon Center for Medical Imaging.

July 18th, 2022: Ph.D. thesis defense scheduled to present my work on “Multi-Modal Imaging of Tumor Hypoxia to Improve Radiation Therapy”.

June 2022: Finished co-op at Biogen in Late Discovery Imaging, and back at the University of Chicago for my last quarter as  a PhD candidate.

March 10th, 2022: Invited talk at O2M Technologies. More info/registration link here.

January 2022: Starting a co-op at Biogen in the Research and Early Development Biomarkers department for Late Discovery Imaging.

December 2nd, 2021: Oral presentation at the Radiological Society of North America Annual Meeting on "Validation of multimodal hypoxia imaging using pO2 EPR, FMISO PET, and DCE MRI with H&E, CD31, and HIF1 α staining on SCC7 squamous cell carcinomas." 

July 29th, 2021: Oral presentation at the International Society on Oxygen Transport to Tissue on "Validation and correction of [18]F-Misonidazole PET with pO2 EPR and

June 12th, 2021: Selected as the 1st place CMIIT Young Investigator Award recipient at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, for abstract titled “Optimal [18]F-Misonidazole PET threshold to locate SCC7 tumor hypoxia using EPR pO2 as ground truth.”

April 2021: Recipient of an NIH F31 Ruth L. Kirchstein National Research Service Award for my dissertation project: "Correcting [18]F-Misonidazole PET with MRI and EPR to improve hypoxia-guided radiation therapy." 


Small animal IMRT using 3D-printed compensators

Gage Redler, Erik Pearson, Xinmin Liu, Inna Gertsenshteyn, Boris Epel, Charles Pelizzari, Bulent Aydogan, Ralph Weichselbaum, Howard Halpern, Rodney D Wiersma

International Journal of Radiation Oncology, Biology, Physics

Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models

Inna Gertsenshteyn, Boris Epel, Mihai Giurcanu, Eugene Barth, John Lukens, Kayla Hall, Jenipher Flores Martinez, Mellissa Grana, Matthew Maggio, Richard C. Miller, Subramanian V. Sundramoorthy, Martyna Krzykawska-Serda, Erik Pearson, Bulent Aydogan, Ralph R. Weichselbaum, Victor M. Tormyshev, Mrignayani Kotecha, Howard J. Halpern

Frontiers in Medicine, vol. 10, 2023

The optimal 18F-Fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth.

Inna Gertsenshteyn, Boris Epel, Amandeep Ahluwalia, Heejong Kim, Xiaobing Fan, Eugene Barth, Marta Zamora, Erica Markiewicz, Hsui-Ming Tsai, Subramanian Sundramoorthy, Lara Leoni, John Lukens, Mohammed Bhuiyan, Richard Freifelder, Anna Kucharski, Mihai Giurcanu, Gregory Karczmar Brian Roman, Chien-Min Kao, Howard Halpern, Chin-Tu Chen

European Journal of Nuclear Medicine and Molecular Imaging, 2022

Development of a PET/EPRI combined imaging system for assessing tumor hypoxia

Heejong Kim, Boris Epel, Subraman Sundramoorthy, Hsiu-Min Tsai, Eugene Barth, Inna Gertsenshteyn, Howard Halpern, Yuexuan Hua, Qingguo Xie, Chin-Tu Chen, Chien-Min Kao

Journal of Instrumentation, vol. 16, 2021

View all


Inna Gertsenshteyn


Gordon Center for Medical Imaging

Massachusetts General Hospital


Follow this website

You need to create an Owlstown account to follow this website.

Sign up

Already an Owlstown member?

Log in